about
In vitro and in vivo induction and activation of nNOS by LPS in oligodendrocytesNeuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.Flow cytometric analysis reveals the high levels of platelet activation parameters in circulation of multiple sclerosis patients.MALDI mass spectrometry based molecular phenotyping of CNS glial cells for prediction in mammalian brain tissue.The role of advanced magnetic resonance imaging techniques in primary progressive MS.Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study.The blood-brain barrier in health and disease.7 Tesla magnetic resonance imaging to detect cortical pathology in multiple sclerosis.Systemic inflammation in progressive multiple sclerosis involves follicular T-helper, Th17- and activated B-cells and correlates with progression.Involvement of oxidative stress in occurrence of relapses in multiple sclerosis: the spectrum of oxidatively modified serum proteins detected by proteomics and redox proteomics analysisSera from remitting and secondary progressive multiple sclerosis patients disrupt the blood-brain barrierRelationship between the Increased Haemostatic Properties of Blood Platelets and Oxidative Stress Level in Multiple Sclerosis Patients with the Secondary Progressive StageTargeting B cells in the treatment of multiple sclerosis: recent advances and remaining challenges.Effects of intraventricular methotrexate administration on Cuprizone-induced demyelination in mice.Glial response during cuprizone-induced de- and remyelination in the CNS: lessons learned.Lymph node dissection--understanding the immunological function of lymph nodes.Use of Magnetic Resonance Imaging as Well as Clinical Disease Activity in the Clinical Classification of Multiple Sclerosis and Assessment of Its Course: A Report from an International CMSC Consensus Conference, March 5-7, 2010A review of genome-wide association studies for multiple sclerosis: classical and hypothesis-driven approaches.Multiple sclerosis: a disorder of altered T-cell homeostasisFurther understanding of the immunopathology of multiple sclerosis: impact on future treatments.Ongoing Oxidative Stress Causes Subclinical Neuronal Dysfunction in the Recovery Phase of EAE.Peripheral Inflammation and Demyelinating Diseases.Multicontrast MRI Quantification of Focal Inflammation and Degeneration in Multiple Sclerosis.Effects of 2-chlorodeoxyadenosine (Cladribine) on primary rat microglia.Identification of risk loci for necrotizing meningoencephalitis in Pug dogs.Primary progressive versus relapsing-onset multiple sclerosis: presence and prognostic value of cerebrospinal fluid oligoclonal IgM.The changing clinical course of multiple sclerosis: a matter of gray matter.Pathological correlates of magnetic resonance imaging texture heterogeneity in multiple sclerosis.7T MRI-Histologic Correlation Study of Low Specific Absorption Rate T2-Weighted GRASE Sequences in the Detection of White Matter Involvement in Multiple Sclerosis.Identification of galectin-3 as a possible antibody target for secondary progressive multiple sclerosis.Local and remote immune-mediated inflammation after mild peripheral nerve compression in rats.Network analysis of transcriptional regulation in response to intramuscular interferon-β-1a multiple sclerosis treatment.Cytokine Profile in Patients with Progressive Multiple Sclerosis and Its Association with Disease Progression and Disability.Disease-modifying therapies for nonrelapsing multiple sclerosis: Costs and benefits of medical intervention
P2860
Q28570362-93A6F330-E2CB-4DA6-8526-D379C01C84BDQ30576477-A6778730-F142-439B-B837-59B15152A4C0Q33705173-35D03380-E6E9-41C5-B040-AF77EE5EC74BQ33892813-71A4AD68-8802-4D5E-85D9-DEB31355BD9AQ33981654-8707FDFB-6532-4DD8-AA3A-24C1A7CDCFC0Q34301521-A6967011-A0BE-4D45-A30D-DE7461B71005Q34320420-086618CB-7B9A-4A13-9954-F9CC026D440FQ34323147-DBB2E0DB-5440-46BD-96A1-D48BF8E4346CQ34613311-473A9815-59E9-4E4D-8EF7-27D83C610D71Q34769676-0CD457A3-C1C0-4A2A-98B3-A4CB2C8AD9F7Q35136280-A553E318-46F1-47E4-9DED-1E0B95EEEE52Q35598836-206403B0-1944-43E9-95D7-AF26C47054E0Q36761844-3721CB9D-CAAC-4348-9369-099A2C874F90Q37231678-41FAAD33-7F50-415B-97B7-4F1397D1ECB8Q37634375-A8F52574-47B5-4E15-979A-2F3F992ED692Q38031923-77C6FE4B-2453-479D-A378-F403E832515CQ38181064-96CC8F98-F525-4747-AA0A-C4212A8F9FA6Q38593055-1C46F003-5E95-4856-9B16-80D10E59425AQ38760373-687375B1-E85A-414F-B0C1-AA590886C7E1Q38837294-584E4F7C-6489-4AED-BA11-EA199BB9D13AQ38964016-8940B0B9-E049-4C89-970E-1A0DA1B6A652Q38974745-92F208D5-E2F5-427E-A57F-EAE13ECC91FFQ42433959-56B391AE-38E5-4C1A-8C8F-73EBF7DBCCABQ42660093-F6984725-F793-4BFB-9BFA-7275F1051BBBQ44539038-7806FF0C-DDD0-4289-95DE-C0E8562F57E7Q46028716-E426F70D-6234-4152-9B44-D879C88BDAB4Q46292409-92B45853-DF84-4381-BD25-BD2F41172192Q47793639-8456AD6C-2320-4493-B870-21CD79E7153CQ48217899-2A615288-38A4-48DA-A34A-F7B3CB6A0A85Q48658707-BEECD6B5-EA5B-4A1F-A591-AEDB88589C28Q50903814-7A97DB83-6CD2-431F-BD96-AC67B2CF4178Q51646400-A00EDFA3-4D3F-4B56-8A33-BA08980708B8Q52143402-D0ED61C7-22DD-476F-B7C8-8F258787C449Q56882349-7A9F8371-FDCF-42C8-9142-B615BA3FC782
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Progressive multiple sclerosis.
@en
Progressive multiple sclerosis.
@nl
type
label
Progressive multiple sclerosis.
@en
Progressive multiple sclerosis.
@nl
prefLabel
Progressive multiple sclerosis.
@en
Progressive multiple sclerosis.
@nl
P2860
P1476
Progressive multiple sclerosis
@en
P2093
Monika Bradl
P2860
P2888
P304
P356
10.1007/S00281-009-0182-3
P577
2009-11-01T00:00:00Z